Taiwan to start clinical trials on antiviral drug remdesivir
Taipei, Feb. 26 (CNA) National Taiwan University Hospital (NTUH) has consulted with the United States and is to start clinical trials in Taiwan of the antiviral drug remdesivir for the treatment of COVID-19 coronavirus, the Central Epidemic Command Center (CECC) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Taiwan barista comes third at World Latte Art Championship06/26/2022 09:19 PM
Taiwan wins recurve women's team gold at Archery World Cup06/26/2022 07:57 PM
Vice President's herniated disk surgery successful: Presidential Office06/26/2022 06:49 PM
Mohammad Al Bachir Gadiaga named T1 LEAGUE rookie of the year06/26/2022 06:27 PM